MedTrace Logo

An Exploratory Investigation of Dietary Supplementation and Its Effect

NCT05037877 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2022-04-08

No results posted yet for this study

Summary

The primary objective of this study is to understand if the test product (HUM supplement) improve symptoms experienced.

Conditions

  • Quality of Life

Interventions

DIETARY_SUPPLEMENT

HUM supplement

HUM supplement - 1 capsule per day

DIETARY_SUPPLEMENT

Placebo

Placebo supplement - 1 capsule per day

Sponsors & Collaborators

  • Citruslabs

    collaborator INDUSTRY

  • HUM Nutrition, Inc.

    lead INDUSTRY

Principal Investigators

  • Susanne Mitschke · Citruslabs

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
38 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-31
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05037877 on ClinicalTrials.gov